|
|
ENTEREG®
Entereg (alvimopan) is approved to accelerate the restoration of normal bowel function in patients 18 years and up who have undergone partial large or small bowel resection surgery.more detail |
|
|
|
TACLONEX®
Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis. more detail |
|
|
|
RELISTOR®
Relistor (methylnaltrexone bromide) has been approved to help restore bowel function in patients with late-stage, advanced illness who are receiving opioids on a continuous basis to help alleviate their pain.
more detail |
|
|
|
ARTISS®
ARTISS [Fibrin Sealant (Human)], the first and only slow-setting fibrin sealant indicated for use in adhering skin grafts in adult and pediatric burn patients. more detail |
|
|
|
ARCALYST™
Arcalyst (rilonacept, an Interleukin-1 blocker) is now approved for the long term treatment of two Cryopyrin-Associated Periodic Syndromes (CAPS) disorders: Familial Cold Auto-Inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
more detail |
|